SCHEMBL21165607

SCHEMBL21165607

c1ccc(-c2ccc(-n3c4ccc(-c5ccc6c(c5)c5ccccc5n6-c5cc(-c6ccccc6)ccc5-c5ccccc5)cc4c4c(-c5cccc(-c6cccc(-c7ccccc7)c6)c5)cccc43)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TSPO P30536 5/20 0.37
HDAC4 P56524 1/20 0.37
ALK Q9UM73 3/20 0.36
DNM1 Q05193 1/20 0.33
PDE6D O43924 1/20 0.32
JAK2 O60674 1/20 0.32
JAK3 P52333 1/20 0.32
AKR1C4 P17516 1/20 0.31
AKR1C3 P42330 1/20 0.31
AKR1C2 P52895 1/20 0.31
AKR1C1 Q04828 1/20 0.31
MAPK14 Q16539 1/20 0.31
ALDH1A1 P00352 1/20 0.31
KMT2A Q03164 1/20 0.30
IL1R1 P14778 1/20 0.30
CAMKK2 Q96RR4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21165586 1.00 KDM4E (0.40) KDM4EATML3MBTL1TSPOHDAC4
SCHEMBL21165580 1.00 KDM4E (0.40) KDM4EATML3MBTL1TSPOHDAC4
SCHEMBL21165701 1.00 KDM4E (0.40) KDM4EATML3MBTL1TSPOHDAC4
SCHEMBL21165595 0.99 ATM (0.41) KDM4EATML3MBTL1TSPOHDAC4
SCHEMBL21165566 0.98 L3MBTL1 (0.43) KDM4EATML3MBTL1TSPOHDAC4
SCHEMBL21165581 0.98 L3MBTL1 (0.43) KDM4EATML3MBTL1TSPOHDAC4
SCHEMBL21165620 0.98 L3MBTL1 (0.43) KDM4EATML3MBTL1TSPOHDAC4
SCHEMBL21165582 0.98 L3MBTL1 (0.43) KDM4EATML3MBTL1TSPOHDAC4
SCHEMBL21165639 0.98 ATM (0.41) KDM4EATML3MBTL1TSPOHDAC4
SCHEMBL21165615 0.98 ATM (0.41) KDM4EATML3MBTL1TSPOHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190221750-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190221750-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CRY1, CRY2, MCM4 KDM4E 3296/4885ATM 1310/4885L3MBTL1 2041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.